Michelle Arya

Michelle Arya has a robust background in quality control and molecular biology, currently serving as Lab Operations Manager for Gene Therapy Quality Control at Sarepta Therapeutics since September 2020. Arya's role involves overseeing GMP bioassay and Nucleic Acids Testing within the QC laboratories, ensuring effective laboratory operations. Previous positions include Scientist II in Molecular Biology Quality Control at Sarepta Therapeutics, Senior Quality Control Associate at Beacon Hill Staffing Group, and Senior Scientist at Eurofins Lancaster Laboratories. Arya's experience spans various research and quality control roles in gene therapy, including the development of bioanalytical assays and methods. Educational qualifications include a PhD in Biomedical Sciences from Tufts University, a Master of Liberal Arts in Biology from Harvard University, and a B.Sc. in Molecular & Cellular Biology from Concordia University.